Position Statements

Truth, Justice and Reconciliation

To the CAREB-ACCER and broader Research Ethics Community: There is a need for action, accountability, [...]

Read More
CAREB-ACCER’s comments in response to the CCTCC REB Accreditation Working Group Consultation

In May 2016, the REB Accreditation Working Group of the Canadian Clinical Trials Coordinating Centre (CCTCC) released its Draft [...]

Read More
CAREB-ACCER Response to Draft RDM Policy – 2018

File: CAREB-ACCER Response to Draft RDM Policy – 2018

Read More
CAREB-ACCER’s response to the U.S. Notice of Proposed Rulemaking (NPRM) – Federal Policy for the Protection of Human Subjects

In September, 2015, the U.S. Department of Health and Human Services (HHS) and fifteen other [...]

Read More
Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators

October 2011 – The CAREB Board of Directors recently filed comments to the Department of Health and Human [...]

Read More
Responsible Conduct of Research (RCR)

September 2011 – The CAREB Board of Directors filed comments in response to the Tri-Agency’s proposed framework on [...]

Read More
Reporting of Unanticipated Problems including Adverse Events to Research Ethics Boards in Canada

July 2010 – CAREB issued their first guidance document Reporting of Unanticipated Problems including Adverse Events to [...]

Read More